About this trial
This proposal seeks to carry out a double-blinded, randomized, comparative study that investigates neurobehavioral changes induced by personalized, anxiosomatic and dysphoric network guided accelerated intermittent-theta burst (iTBS) using dense functional Magnetic Resonance Imaging (fMRI) sampling in participants with treatment-resistant depression (TRD) and moderate/high levels of anxiety.
Eligibility criteria
Qualifiers
Male/female aged 21-70
Diagnosis of MDD as validated by MINI
Non-response to adequate trial (4 weeks) of at least two MDD medication as verified by the study clinician
BDI score of 20 or above; BAI score of 16 or above
Disqualifiers
DSM-5 psychotic disorder
Drug or alcohol abuse or dependence (preceding 3 months)
Rapid clinical response required, e.g., high suicide risk
Significant neurological disorder, which may pose increased risks with TMS, e.g., epilepsy
Trial design
Treatments tested in this trial
- Individualized connectome-guided accelerated iTBS
Treatment groups
Sponsors and collaborators
National University Hospital, Singapore
Lead sponsor
National University of Singapore
Collaborator